Cited by 391Genetic Syndromes and ImprintingGenetics and Neurodevelopmental DisordersEpigenetics and DNA Methylation

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

Open access

Huang, Hsien-Sung, Allen, John A., Mabb, Angela M., King, Ian F., Miriyala, Jayalakshmi, Taylor-Blake, Bonnie, Sciaky, Noah, Dutton, J. Walter, Lee, Hyeong-Min, Chen, Xin, Jin, Jian, Bridges, Arlene S., Zylka, Mark J., Roth, Bryan L., Philpot, Benjamin D.·2012·Nature

DOI 10.1038/nature10726PMC PMC3257422

Open this paper in CoChat — free account

Abstract

Angelman syndrome is a severe neurodevelopmental disorder caused by deletion or mutation of the maternal allele of the ubiquitin protein ligase E3A (UBE3A). In neurons, the paternal allele of UBE3A is intact but epigenetically silenced, raising the possibility that Angelman syndrome could be treated by activating this silenced allele to restore functional UBE3A protein. Using an unbiased, high-content screen in primary cortical neurons from mice, we identify twelve topoisomerase I inhibitors and four topoisomerase II inhibitors that unsilence the paternal Ube3a allele. These drugs included topotecan, irinotecan, etoposide and dexrazoxane (ICRF-187). At nanomolar concentrations, topotecan upregulated catalytically active UBE3A in neurons from maternal Ube3a-null mice. Topotecan concomitantly downregulated expression of the Ube3a antisense transcript that overlaps the paternal copy of Ube3a. These results indicate that topotecan unsilences Ube3a in cis by reducing transcription of an imprinted antisense RNA. When administered in vivo, topotecan unsilenced the paternal Ube3a allele in several regions of the nervous system, including neurons in the hippocampus, neocortex, striatum, cerebellum and spinal cord. Paternal expression of Ube3a remained elevated in a subset of spinal cord neurons for at least 12 weeks after cessation of topotecan treatment, indicating that transient topoisomerase inhibition can have enduring effects on gene expression. Although potential off-target effects remain to be investigated, our findings suggest a therapeutic strategy for reactivating the functional but dormant allele of Ube3a in patients with Angelman syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10726

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Image processing with ImageJ
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1977 · Cited by 2,362
Stability and flexibility of epigenetic gene regulation in mammalian development
Reik, W. (2007) · Nature · doi:10.1038/nature05918 · Cited by 1,963 · cited 1×
“Genomic imprinting is thought to be established only during prescribed germline and embryonic periods of development and imprinted genes typically remain epigenetically regulated throughout lif”
Background
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. E. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,304
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Scheffner, M., Nuber, U. A., & Huibregtse, J. M. (1995) · Nature · doi:10.1038/373081a0 · Cited by 1,017
CellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 880
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R. H., Jiang, Y., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 858
Mutation of the Angelman Ubiquitin Ligase in Mice Causes Increased Cytoplasmic p53 and Deficits of Contextual Learning and Long-Term Potentiation
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons
Albrecht, U., Sutcliffe, J. S., Cattanach, B. M., BEECHEY, C. V., Armstrong, D. L., Gregor Eichele, C., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 587
Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism
Nakatani, J., Tamada, K., Hatanaka, F., Ise, S., Ohta, H., Inoue, K., Tomonaga, S., Watanabe, Y., Chung, Y. J., Banerjee, R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.024 · Cited by 482

Show all 38 references

Sorted by citations

Items 201–300 of 391

RBFOX1 and RBFOX2 are dispensable in iPSCs and iPSC-derived neurons and do not contribute to neural-specific paternal UBE3A silencing
Chen, P.-F., Hsiao, J. S., Sirois, C. L., & Chamberlain, S. J. (2016) · Scientific Reports · doi:10.1038/srep25368 · Cited by 21
AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription
Bazick, H., Mao, H., Niehaus, J. K., Wolter, J. M., & Zylka, M. J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.032 · Cited by 20
Self-citation
Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader–Willi syndrome
Wong, S., Wang, T., Tsai, W., & Tsai, L. (2019) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_103_19 · Cited by 20
Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide
Huang, B., Zhou, L., Liu, R., Wang, L., Xue, S., Shi, Y., Jeong, G. H., Jeong, I. H., Li, S., Yin, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01922 · Cited by 20
In Vitro Corticogenesis from Embryonic Stem Cells Recapitulates the In Vivo Epigenetic Control of Imprinted Gene Expression
Bouschet, T., Dubois, E., Reynès, C., Kota, S. K., Rialle, S., Maupetit‐Mehouas, S., Pezet, M. G., Digarcher, A. L., Nidelet, S., Demolombe, V., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw102 · Cited by 22
Ubiquitin system mutations in neurological diseases
Zenge, C., & Ordureau, A. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.06.011 · Cited by 20
Publisher's note
Tordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 19
Epigenetic editing alleviates Angelman syndrome phenotype in mice by unsilencing paternal Ube3a
Liu, Y., Lou, S., Li, J., Liu, Y., Huang, S., Yu, W., Liu, J., Lv, R., Tang, J., Shen, Z., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00727-3 · Cited by 18
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A -ATS with long-lasting effect in monkeys
Jagasia, R., Bon, C., Rasmussen, S. V., Badillo, S., Tehler, D., Buchy, D., Berrera, M., Prasad, M. K., Chamberlain, S. J., Terrigno, M., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf851 · Cited by 18
Current and emerging treatment options for Angelman syndrome
Keary, C. J., & McDougle, C. J. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2245568 · Cited by 19
Innovation in academic chemical screening: filling the gaps in chemical biology
Hasson, S. A., & Inglese, J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.018 · Cited by 18
A review of Rett syndrome (RTT) with induced pluripotent stem cells
Vellingiri, B., Dhivya, V., Mohan, G., Mohanadevi, S., Venkatesh, B., & Geetha, B. (2016) · Stem Cell Investigation · doi:10.21037/sci.2016.09.05 · Cited by 19
Towards an understanding of Angelman syndrome in mice studies
Yang, X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24576 · Cited by 18
Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation
Delahanty, R., Zhang, Y., Bichell, T. J., Shen, W., Verdier, K. M., Macdonald, R. L., Xu, L., Boyd, K. L., WILLIAMS, J., & Kang, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.067 · Cited by 18
In Silico Molecular Comparisons of C. elegans and Mammalian Pharmacology Identify Distinct Targets That Regulate Feeding
Lemieux, G. A., Keiser, M. J., Sassano, M. F., Laggner, C., Mayer, F., Bainton, R. J., Werb, Z., Roth, B. L., Shoichet, B. K., & Ashrafi, K. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001712 · Cited by 18
Self-citation
Analysis of experience-regulated transcriptome and imprintome during critical periods of mouse visual system development reveals spatiotemporal dynamics
Hsu, C.-L., Chou, C., Huang, S.-C., Lin, C., Lin, M.-Y., Tung, C.-C., Lin, C.-Y., Lai, I. P., Zou, Y., Youngson, N. A., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy023 · Cited by 18
Self-citation
Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome
Krzeski, J. C., Judson, M. C., & Philpot, B. D. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102899 · Cited by 18
Self-citation
Clinical epigenetics: a primer for the practitioner
Aygun, D., & Bjornsson, H. T. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14398 · Cited by 17
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
Kumar, V., Joshi, T., Vatsa, N., Singh, B. K., & Jana, N. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00289 · Cited by 18
Enhanced Nociception in Angelman Syndrome Model Mice
McCoy, E. S., Taylor‐Blake, B., Aita, M., Simon, J. M., Philpot, B. D., & Zylka, M. J. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1018-17.2017 · Cited by 18
Self-citation
FMRP binding to a ranked subset of long genes is revealed by coupled CLIP and TRAP in specific neuronal cell typesPreprint
Driesche, S. J. V., Sawicka, K., Zhang, C., Hung, K. Y. S., Park, C. Y., Fak, J. J., Yang, C., Darnell, R. B., & Darnell, J. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/762500 · Cited by 17
Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases
Chaudhary, P., Proulx, J. M., & Park, I.-W. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199191 · Cited by 16
Epigenetics in rare neurological diseases
Roberts, C.-T., Arezoumand, K. S., Shahib, A. K., Davie, J., & Rastegar, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1413248 · Cited by 16
H2O2 Induces Myocardial Hypertrophy in H9c2 Cells: A Potential Role of Ube3a
Song, R., Zhang, J., Zhang, L., Wang, G., Wo, D., Feng, J., Li, X., & Li, J. (2014) · Cardiovascular Toxicology · doi:10.1007/s12012-014-9264-0 · Cited by 16
How Animal Models Inform Child and Adolescent Psychiatry
Stevens, H. E., & Vaccarino, F. M. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.01.019 · Cited by 18
Known unknowns for allele-specific expression and genomic imprinting effects
Gregg, C. J. (2014) · F1000Prime Reports · doi:10.12703/p6-75 · Cited by 16
Pharmacological therapies for Angelman syndrome
Tan, W., & Bird, L. M. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0408-z · Cited by 20
Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep
Levin, Y., Hosamane, N. S., McNair, T. E., Kunnam, S. S., Philpot, B. D., Fan, Z., & Sidorov, M. S. (2022) · Autism Research · doi:10.1002/aur.2709 · Cited by 16
Self-citation
Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
Tanas, J. K., Kerr, D. D., Wang, L., Rai, A., Wallaard, I., Elgersma, Y., & Sidorov, M. S. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02206-3 · Cited by 18
Spatial and temporal silencing of the human maternal UBE3A gene
Daily, J., Smith, A., & Weeber, E. J. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.03.006 · Cited by 15
Analysis of Genome-Wide Monoallelic Expression Patterns in Three Major Cell Types of Mouse Visual Cortex Using Laser Capture Microdissection
Lin, C., Huang, S.-C., Tung, C.-C., Chou, C., Gau, S. S., & Huang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163663 · Cited by 15
Self-citation
Neurodevelopmental outcomes in children with Angelman syndrome after 1 year of behavioural intervention
Summers, J. (2012) · Developmental Neurorehabilitation · doi:10.3109/17518423.2012.676101 · Cited by 15
UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies
Roy, B., Amemasor, E., Hussain, S., & Castro, K. (2023) · Diseases · doi:10.3390/diseases12010007 · Cited by 15
Regional and cellular organization of the autism-associated protein UBE3A/E6AP and its antisense transcript in the brain of the developing rhesus monkey
Ramirez, C. G., Salvador, S. G., Patel, R. K. R., Clark, S., Miller, N. W., James, L. M., Ringelberg, N. W., Simon, J. M., Bennett, J., Amaral, D. G., et al. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1410791 · Cited by 14
Self-citation
Drugs to awaken a paternal gene
Beaudet, A. L. (2011) · Nature · doi:10.1038/nature10784 · Cited by 14
Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models
Cheng, K., Li, Y., Chang, W., Chen, Z., Cheng, J., & Tsai, C.-C. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.08.002 · Cited by 14
Angelman syndrome: A review highlighting musculoskeletal and anatomical aberrations
Sachdeva, R., Donkers, S. J., & Kim, S. Y. (2015) · Clinical Anatomy · doi:10.1002/ca.22659 · Cited by 14
Gene regulation by convergent promoters
Wiechens, E., Vigliotti, F., Siniuk, K., Schwarz, R. J., Schwab, K., Riege, K., van Bömmel, A., Görlich, I., Bens, M., Sahm, A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-02025-w · Cited by 17
Behavioural effects of imprinted genes
Davies, J. R., Dent, C. L., McNamara, G. I., & Isles, A. R. (2014) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2014.07.008 · Cited by 13
Recent advances and future prospects in direct cardiac reprogramming
Xie, Y., Handel, B. V., Li, Q., & Ardehali, R. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00377-w · Cited by 12
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
Yang, X., & Huang, Y. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052304 · Cited by 12
A blueprint for research on Shankopathies: A view from research on autism spectrum disorder
Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 13
The Role of Noncoding RNAs in Neurodevelopmental Disorders: The Case of Rett Syndrome
Obiols-Guardia, A., & Guil, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_2 · Cited by 12
Neurologic orphan diseases: Emerging innovations and role for genetic treatments
Kioutchoukova, I. P., Foster, D. T., Thakkar, R. N., Foreman, M. A., Burgess, B. J., Toms, R., Valero, E., & Lucke-Wold, B. P. (2023) · World Journal of Experimental Medicine · doi:10.5493/wjem.v13.i4.59 · Cited by 11
Understanding ubiquitination in neurodevelopment by integrating insights across space and time
Ambrozkiewicz, M. C., & Lorenz, S. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01422-3 · Cited by 12
Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments
Walkley, S. U., Abbeduto, L., Batshaw, M. L., Bhattacharyya, A., Bookheimer, S. Y., Christian, B. T., Constantino, J. N., de Vellis, J., Doherty, D., Nelson, D. L., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25531 · Cited by 11
Promising therapeutic aspects in human genetic imprinting disorders
Chao, Y., Qin, Y., Zou, X., Wang, X., Hu, C., Xia, F., & Zou, C. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01369-6 · Cited by 14
PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin
Mouly, L., Mamouni, K., Gence, R., Cristini, A., Cherier, J., Castinel, A., Legrand, M., Favre, G., Sordet, O., & Monferran, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0981-3 · Cited by 11
Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model
Panov, J., & Kaphzan, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105180 · Cited by 11
Autism Spectrum Disorders
Anderson, M. P. (2018) · Wiley eBooks · doi:10.1002/9781119013112.ch40 · Cited by 11
Mining and modeling human genetics for autism therapeutics
Smith, D. G., & Ehlers, M. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.03.004 · Cited by 10
Nervous system development and disease: A focus on trithorax related proteins and chromatin remodelers
Moccia, A., & Martin, D. M. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.016 · Cited by 11
Decoherence and Fidelity in Teleportation of Coherent Photon-Added Two-Mode Squeezed Thermal States
Li, H.-M., Yuan, H., Wan, Z.-L., & Wang, Z. (2017) · International Journal of Theoretical Physics · doi:10.1007/s10773-017-3626-x · Cited by 10
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease
Shekhar, S., Vatsa, N., Kumar, V., Singh, B. K., Jamal, I., Sharma, A., & Jana, N. R. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw398 · Cited by 10
Xist condensates: perspectives for therapeutic intervention
Perotti, I., Broglia, L., Tartaglia, G. G., & Cerase, A. (2025) · Genome biology · doi:10.1186/s13059-025-03666-8 · Cited by 11
AAV-dCas9 vector unsilences paternal Ube3a in neurons by impeding Ube3a-ATS transcription
Wolter, J. M., James, L. M., Boeshore, S. L., Mao, H., McCoy, E. S., Ryan, D. F., Fragola, G., Taylor‐Blake, B., Stein, J. L., & Zylka, M. J. (2025) · Communications Biology · doi:10.1038/s42003-025-08794-2 · Cited by 9
Self-citation
Stem cell models of Angelman syndrome
dos Santos, J. C., Appleton, C., Mateus, F. C., Covas, R., Bekman, E., & da Rocha, S. T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1274040 · Cited by 9
Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14–18, 2012
Anderson‐Schmidt, H., Beltcheva, O., Brandon, M. D., Byrne, E. M., Chater‐Diehl, E., Duncan, L. E., Gonzalez, S., Hannon, E. J., Kantojärvi, K., Karagiannidis, I., et al. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32132 · Cited by 9
Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndromePreprint
Schultz, M. N., & Crawley, J. N. (2020) · Learning & Memory · doi:10.1101/lm.051201.119 · Cited by 10
DNA methylation is a key mechanism for maintaining monoallelic expression on autosomesPreprint
Gupta, S., Lafontaine, D. L. J., Vigneau, S., Vinogradova, S., Mendelevich, A., Igarashi, K. J., Bortvin, A. N., Pereira, C., Clement, K., Pinello, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.20.954834 · Cited by 9
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome
Samanta, D. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2105141 · Cited by 8
cisASE: a likelihood-based method for detecting putative cis -regulated allele-specific expression in RNA sequencing data
Liu, Z., Gui, T., Wang, Z., Li, H., Fu, Y., Dong, X., & Li, Y. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw416 · Cited by 8
Multiscale spatio-temporal dynamics of UBE3A gene in brain physiology and neurodevelopmental disorders
Biagioni, M., Baronchelli, F., & Fossati, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106669 · Cited by 7
Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome
Bazick, H., James, L. M., Taylor‐Blake, B., Wolter, J. M., & Zylka, M. J. (2025) · Gene Therapy · doi:10.1038/s41434-025-00582-1 · Cited by 7
Self-citation
Quantifying Genomic Imprinting at Tissue and Cell Resolution in the Brain
Varrault, A., Dubois, E., Digarcher, A. L., & Bouschet, T. (2020) · Epigenomes · doi:10.3390/epigenomes4030021 · Cited by 8
A long genetic explanation
Plasschaert, R. N., & Bartolomei, M. S. (2013) · Nature · doi:10.1038/nature12553 · Cited by 7
Rationale for haploinsufficiency correction therapy in neurofibromatosis type 1
Frost, M., Serra, E., Viskochil, D. H., Korf, B. R., Mattson-Hoss, M. K., Croston, G. E., & Sarnoff, H. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2022.14 · Cited by 6
Cancer drug repurposing in autism spectrum disorder
Pedini, G., Chen, C., Achsel, T., & Bagni, C. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.09.008 · Cited by 7
Neurodevelopmental Underpinnings of Angelman Syndrome
Li, G. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000111 · Cited by 6
Characterizing spine issues: If offers novel therapeutics to Angelman syndrome
Yang, X. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22757 · Cited by 7
IPSC Models of Chromosome 15Q Imprinting Disorders: From Disease Modeling to Therapeutic Strategies
Germain, N. D., Levine, E. S., & Chamberlain, S. J. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_3 · Cited by 7
Therapeutic strategies for fragile X syndrome and implications for other gene-silencing disorders
Gadban, A., Gunapala, K. M., Taylor, V., & Benvenisty, N. (2025) · Nature Genetics · doi:10.1038/s41588-025-02255-6 · Cited by 5
Roles of Imprinted Genes in Neural Stem Cells
Hoffmann, A., Daniel, G., Schmidt-Edelkraut, U., & Spengler, D. (2014) · Epigenomics · doi:10.2217/epi.14.42 · Cited by 5
Dissociating motor impairment from five-choice serial reaction time task performance in a mouse model of Angelman syndrome
Negrón-Moreno, P. N., Diep, D. T., Guoynes, C. D., & Sidorov, M. S. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.968159 · Cited by 5
Stem Cell Technology for (Epi)genetic Brain Disorders
Riemens, R. J. M., Soares, E. S., Esteller, M., & Delgado‐Morales, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_23 · Cited by 6
A Scoping Review on Recent Progress on Purpurin and its Derivatives
Rustage, K., Chauhan, P., Kapoor, K., Kumar, M., Baniya, B., & Jain, V. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230220124204 · Cited by 5
` Neurodevelopmental Underpinnings of Angelman Syndrome
Qiu, G. L. S. (2014) · OMICS Journal of Radiology · doi:10.4172/2167-7964.1000111 · Cited by 5
Monoallelic, antisense and total RNA transcription in an in vitro neural differentiation system based on F1 hybrid mice
Kondo, S., Kato, H., Suzuki, Y., Takada, T., Eitoku, M., Shiroishi, T., Suganuma, N., Sugano, S., & Kiyosawa, H. (2019) · Journal of Cell Science · doi:10.1242/jcs.228973 · Cited by 5
Antisense oligonucleotides targeting UBE3A-ATS restore expression of UBE3A by relieving transcriptional interferencePreprint
Germain, N. D., Gorka, D., Drennan, R., Jafar‐Nejad, P., Whipple, A. J., Core, L. J., Levine, E. S., Rigo, F., & Chamberlain, S. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.09.451826 · Cited by 5
Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
Samanta, D. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104527 · Cited by 4
Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1
Tumini, E., Wellinger, R. E., Herrera‐Moyano, E., Navarro-Cansino, P., García-Rubio, M. L., Salas‐Lloret, D., Losada, A., Muñoz-Alonso, M. J., Gaillard, H., Luna, R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2421167122 · Cited by 4
Dietary Intake of Octanoic Acid Restores UBE3A Expression and Improves the Behavioral Phenotypes in a Mouse Model of Angelman Syndrome
Qu, S., Guan, X., Li, H., Yang, J., Sun, P., Song, C., Surzenko, N., & Wang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202403130rr · Cited by 4
From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
Zampeta, F. I., Distel, B., Elgersma, Y., & Iping, R. (2022) · Human Genetics · doi:10.1007/s00439-022-02460-x · Cited by 4
Autism risk gene Cul3 alters neuronal morphology via caspase-3 activity in mouse hippocampal neurons
Xia, Q., Singh, A., Wang, J., Xuan, Z., Singer, J. D., & Powell, C. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1320784 · Cited by 4
Human pluripotent stem cell (hPSC)-derived models for autism spectrum disorder drug discovery
Nie, L., Irwin, C. L., Geahchan, S., & Singh, K. K. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2416484 · Cited by 4
Tyrosine and Phenylalanine Activate Neuronal DNA Repair but Exhibit Opposing Effects on Global Transcription and Adult Female Mice Are Resilient to TyrRS / YARS1 Depletion
Jhanji, M., Bhan, A., Arrowood, C. A., Yakout, D. W., Shroff, A., McManus, D., Gifford, H., Vacharasin, J. M., Lizarraga, S. B., Nazarko, T. Y., et al. (2025) · IUBMB Life · doi:10.1002/iub.70030 · Cited by 4
Self-citation
Integration of microarray profiles associated with cardiomyopathy and the potential role of Ube3a in apoptosis
Zhang, J., Song, R., LI, Y., Feng, J., Peng, L., & Li, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1848 · Cited by 4
Angelman syndrome
Mathews, J. M., Cook, E. K., Margolis, S. S., & Williams, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00024-6 · Cited by 4
Neurobiology of Autism Spectrum Disorders
Martins, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-42713-3_2 · Cited by 4
A human Angelman Syndrome class II pluripotent stem cell line with fluorescent paternal UBE3A reporter
Kelkar, G. R., Stuppy, S. R., Sen, D., Yagci, Z. B., Han, L., Land, L., Hartman, J. K., & Keung, A. J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1665693 · Cited by 3
Towards targeted therapy for Angelman syndrome
Ciarlone, S. L., & Weeber, E. J. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1136557 · Cited by 3
UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes
Nash, K. R., Jinwal, U. K., & Bhat, K. M. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283680 · Cited by 3
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions
Major, R., Mills, C. A., Xing, L., Krantz, J. L., Wolter, J. M., & Zylka, M. J. (2025) · The CRISPR Journal · doi:10.1089/crispr.2024.0074 · Cited by 3
Self-citation
Emerging role of epigenetics in human neurodevelopmental disorders
Mastrototaro, G., Sessa, A., & Zaghi, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00022-1 · Cited by 3
Light activates Ube3a, an Angelman syndrome‐associated gene, by mediating the chromatin structures during postnatal development of mouse retina
Lin, C., Cheng, Y., Yang, C., & Huang, H. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16018 · Cited by 3
Self-citation
Emerging Role of Epigenetics in Human Neurodevelopmental Disorders
Mastrototaro, G., & Sessa, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00009-1 · Cited by 3
Magnetic Alignment of Microelements Containing Cultured Neuronal Networks for High-Throughput Screening
Gordon, K. R., Wang, Y., Allbritton, N. L., & Taylor, A. M. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115598609 · Cited by 3
Epigenetics: From Basic Biology to Chromatin-Modifying Drugs and New Potential Clinical Applications
Matrisciano, F., Panaccione, I., Dong, E., Grayson, D. R., & Guidotti, A. (2015) · Neuromethods · doi:10.1007/978-1-4939-2754-8_1 · Cited by 3
Silent angels the genetic and clinical aspects of Rett syndrome
Dziwota, E., Fałkowska, U., Adamczyk, K., Adamczyk, D., Stefańska, A., Pawęzka, J., & Olajossy, M. (2016) · Current Problems of Psychiatry · doi:10.1515/cpp-2016-0028 · Cited by 3
A High-content Assay for Monitoring AMPA Receptor Trafficking
Ghane, M. A., Yakout, D. W., & Mabb, A. M. (2019) · Journal of Visualized Experiments · doi:10.3791/59048 · Cited by 3
Self-citation

Authors: Huang, H.-S., Allen, J. A., Mabb, A. M., King, I. F., Miriyala, J., Taylor-Blake, B., Sciaky, N., Dutton, J. W., Lee, H.-M., Chen, X., Jin, J., Bridges, A. S., Zylka, M. J., Roth, B. L., & Philpot, B. D.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Zylka, Mark J.
Roth, Bryan L.
Philpot, Benjamin D.
ORCID: Huang, Hsien-Sung
Allen, John A.
Mabb, Angela M.
King, Ian F.
Miriyala, Jayalakshmi
Lee, Hyeong-Min
Chen, Xin
Jin, Jian
Zylka, Mark J.
Roth, Bryan L.
Philpot, Benjamin D.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-12-21
Volume: 481
Issue: 7380
Pages: 185-189
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10726
PMC: PMC3257422
OpenAlex: W2016365513
Cited by: 387
References: 38
Citations by year: 2026: 15 · 2025: 19 · 2024: 18 · 2023: 18 · 2022: 17 · 2021: 15 · 2020: 34 · 2019: 24 · 2018: 22 · 2017: 33 · 2016: 37 · 2015: 34 · 2014: 38 · 2013: 35 · 2012: 26
FWCI: 20.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: U.S. Public Health Service (HHSN-271-2008-00025-C)
National Institute of Mental Health (R01MH093372)
National Eye Institute (R01EY018323)
National Institute of Neurological Disorders and Stroke (R01NS060725, R01NS067688, P30NS045892, F32NS067712)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30-HD03110, P30HD003110, T32HD040127)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords: Angelman syndrome, UBE3A, genomic imprinting, topoisomerase inhibitors, topotecan, epigenetic silencing, antisense RNA, cortical neurons, irinotecan, etoposide, dexrazoxane, drug repurposing, long-term drug effects
MeSH terms: Alleles, Animals, Cells, Cultured, Cerebral Cortex, Drug Evaluation, Preclinical, Fathers, Female, Male, Mice, Inbred C57BL, Mothers, Neurons, Angelman Syndrome, Genomic Imprinting, Topotecan, Gene Silencing, Ubiquitin-Protein Ligases, Mice, Small Molecule Libraries, Topoisomerase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks